AnalystsCarey MacruryCarey Macrury's Stock Forecasts
AnalystsCarey Macrury
Sectors:
Analyst Ranking
Bottom 18%
#4082 out of 4929 analysts
Average Return
-4.05%
Win Rate
60%6 out of 10
Risk vs Reward
Poor
Good
Carey Macrury's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gatos Silver IncGATO | +42.29% | $10.12 | $14.40 | 2024-04-23 - 2025-01-15 | Strong Buy |
Iamgold CorpIAG | +22.42% | $6.11 | $7.48 | 2024-10-22 - 2025-07-03 | Strong Buy |
Newmont CorpNEM | +15.04% | $45.61 | $52.47 | 2022-07-27 - 2023-01-19 | Strong Buy |
Royal Gold IncRGLD | +10.23% | $109.04 | $120.19 | 2022-06-13 - 2023-06-12 | Strong Buy |
Centerra Gold IncCGAU | +7.87% | $9.66 | $10.42 | 2021-04-21 - 2022-04-20 | Buy |
Carey Macrury Analyst Color
Get additional color on Carey Macrury's coverage of popular stocks
Carey Macrury's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Gold Royalty CorpGROY | 1 | Strong Buy | $3.00 | +30.43% | Initiates Coverage On | 24 days ago |
Eldorado Gold CorpEGO | 1 | Hold | $27.00 | +30.00% | Maintains | 2 months ago |
Iamgold CorpIAG | 2 | Strong Buy | $10.50 | +40.37% | Upgrades | 8 months ago |
Gatos Silver IncGATO | 1 | Strong Buy | $12.50 | N/A | Upgrades | a year ago |
Aptose Biosciences IncAPTOF | 1 | Strong Buy | $3,600.00 | N/A | Maintains | 2 years ago |
Newmont CorpNEM | 5 | Strong Buy | $55.00 | N/A | Upgrades | 2 years ago |
Royal Gold IncRGLD | 2 | Strong Buy | $140.00 | N/A | Upgrades | 3 years ago |
Maverix Metals IncMMX | 1 | Strong Buy | $8.25 | N/A | Upgrades | 4 years ago |
Centerra Gold IncCGAU | 1 | Buy | $14.50 | N/A | Downgrades | 4 years ago |
Agnico Eagle Mines LtdAEM | 1 | Strong Buy | $110.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.